Reuters logo
BRIEF-Glenmark Pharma gets ANDA approval for nitroglycerin sublingual tablets
September 20, 2017 / 3:23 AM / 3 months ago

BRIEF-Glenmark Pharma gets ANDA approval for nitroglycerin sublingual tablets

Sept 20 (Reuters) - Glenmark Pharmaceuticals Ltd

* Says receives ANDA approval for nitroglycerin sublingual tablets usp, 0.3 mg, 0.4 mg, and 0.6 mg Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below